MEDICAL PRODUCTS
Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
LOGGED IN
No one logged in.

CELLULAR RENOVATION THERAPY

Cellular Renovation Therapy, developed by BIOCELL ULTRAVITAL in Switzerland and by the Biocell Laboratories in France, is the result of over 70 years of research in cellular biotechnology. Each product line is formulated with 100% natural ingredients, clinically tested, that do not contain drugs, steroids, chemicals or any other substances that pose health risks. The composition of a CRT varies depending on the type of product and its therapeutic effect, significantly differentiating itself from other similar therapies.

Cellular Renovation Therapy is primarily a preventative therapeutic approach. It provides essential nutrients via embryonic opotherapeutic extracts such as phyto-organics, enzymes, amino acids, potent antioxidants to neutralise the action of free radicals, and other recognised non-chemical therapeutic substances that stimulate cell regeneration and revitalisation. These strengthen the nucleus of the cell, the cell's cycles and specific functions in its renewal phase and subsequent mitosis. These 100% compatible components were included in order to enhance traditional organotherapy and cell therapy formulas based purely on opotherapy. The main objective is to revitalise healthy and/or damaged organs, optimising the function of the tissues affected by possible structural changes, especially those to which they are predisposed by genetics or heredity.

Cellular Renovation Therapy has a medium-and long-term effect, stimulating the body’s own mechanisms for revitalisation and healing. Its therapeutic action works as it is incorporated into and accepted as intrinsic, so that it can never injure the receptor body, improving the quality of life in various types of degenerative diseases. CRT does not work like a drug, whereas drugs and chemicals only work until they are broken down by the body's metabolic processes.

How Cellular Renovation Therapy works

Through its exclusive formulas, CRT can transform sick or ageing organs into healthy organs with large functional capacity. Its nutrient-rich and cell-stimulating components can be introduced into the body either orally or by injection.

These different components are delivered to the cells either directly through the bloodstream or indirectly in the case of oral products, and are incorporated into the cells via one of several cellular transport methods, depending on the size of the molecules in question. Large molecules are incorporated into cells via receptor-mediated endocytosis, following the series: vesicle, endosome and lysosome. Smaller molecules are incorporated through either simple diffusion or protein-facilitated diffusion, as applicable. 

Cell Extracts (solid particles) that have entered the cell via endocytosis are made up of molecules whose atoms are joined together by chemical bonds, which contain energy. In order for the cell to be able to utilise the matter and energy, the molecules must first be broken down. This process is called digestion, and is carried out by enzymes in the lysosome.

The useful parts of the cellular extracts pass into the cytoplasm and are assimilated into it. The parts that are not useful are ejected from the cell.

Assimilated substances have different purposes: the matter can be used to make other molecules, to replace destroyed parts of the cell structure(regeneration), or to release energy.

The incorporation of these various components into the relevant cell tissues is facilitated by the empathy existing between these components and the receptor proteins on the surface of the cell membrane in question. Following their incorporation, stimulating biochemical changes will occur that will lead to effective CELLULAR RENOVATION THERAPY.

CRT provides cells that are short on proteins, amino acids, enzymes and a large number of biochemical substrates and nutrients with the elements they need, stimulating cell renewal. This process is assisted by nucleic acids that help to correct DNA damage and get past cell controls in order to achieve a healthy mitosis of the renewed cells in the various organs and glands targeted by the treatment.

Each CRT formula contains cells and embryonic tissues that stimulate positive changes in the cell cycle, partly filling any dysfunctional gaps. This is how the different components are primarily incorporated as essential nutrients and also how the embryonic tissues reach the under-performing organ in need of revitalisation.

This process is referred to as the CELLULAR RENOVATION THERAPY stage, and its beneficial effect is seen after several weeks as it passes slowly from cell to tissue, tissue to organ, and organ to system. Some experts claim that the most important result that comes from using CRT is the revitalisation of the immune system’s defence mechanisms.

CELLULAR RENOVATION THERAPY PRODUCTS

There is currently a growing interest in cellular therapy based on stem cells extracted from the patients themselves; these procedures are very costly, risky and still in the experimental phase. In contrast, CRT products provide sustained results with no risk of complications and in comparison represent a huge financial saving.

Cellular Renovation Therapy product lines are divided into 5 main groups: Regeneration, Revitalisation, Detoxification, Anti-inflammatory and Pro-hormonal.

The Cellorgane Complex and Multicomplex product lines have been developed to revitalise every organ and system in the human body, and provide optimal cell function through principles similar to human stem cell therapies. However, instead of extracting stem cells, which are undifferentiated cells, the Cellorgane Complex CRT begins with the selection of cells from a specific organ belonging to a sheep or pig embryo.

Cellorgane Complex, an immunological embryonic organotherapy, is formulated with several compounds, with those from the corresponding embryonic tissue group taking prominence, namely either ectoderm, endoderm or mesoderm. More favourable results have been reported using this therapy than other more well-known conventional cell therapies and organotherapies. Cellorgane Complex or Multi-Complex has surpassed the effectiveness of its predecessor by 80-85% in the target organ treated. In addition to a direct beneficial effect, it also produced a positive indirect result of 15-20% in the rest of the other organs belonging to the same embryonic tissue group.

Example 1: Formula number 7 is recommended for the central nervous system (brain), which is derived from ectoderm. Application of the formula also resulted in a slight improvement in the other organs derived from ectoderm (bone, eye, hypothalamus, pituitary, skin and spinal cord). Cell tissues from the thymus gland were also included in the formula, as this is a leading component of the immune system. The thymus is the central organ of initial immunity, whose function declines with age. It is a primary organ that participates in the maturation of immune cells, called T lymphocytes. The thymus cells in the formula also stimulate production of 2 essential proteins: Thymic protein, which has an effect on prothymocyte feeder cells, and thymuline, which stimulates the immunocompetence of T lymphocytes.

The opposite occurs in the case of CRT Human Ultracell 2G and 3G, which provide cells with a general regeneration that benefits the whole human body, as it acts on the same principle as pluripotent stem cells, through cell differentiation, offering improvements in: cognition, muscle strength, energy levels, aerobic and cardiac capacity, libido, skin quality and renal, pancreatic, hepatic and endocrine function. This contributes to a significant improvement in the quality of life.

CRT has been hugely successful in recent years as a preventative treatment, without discounting its effectiveness as a mainstream therapy, as its benefits are well-known for their coadjutant effect in allopathic medicine.

It is marketed exclusively through medical specialists, who determine individuals’ biological vs. chronological age, and assess their family background, clinical information, habits, lifestyle and other factors for consideration before prescribing a Cellular Renovation Therapy.

PRELIMINARY TESTS

It is important to carry out an initial basic laboratory "check up" on patients, consisting of a blood count, 35-element blood chemistry screen, general urinalysis and prostate-specific antigen test (males) and PAP smear test (females).

For people with a family history of thyroid disorders, a complete thyroid profile is also recommended.

We recommend that a detox program using products such as Celltox and Mekenz H7 from the Biocell Ultravital line be undertaken before any CRT is administered.

TREATMENT OPTIONS

Based on the results of these tests and measurements, each patient will be offered an alternative treatment in keeping with his or her needs and possibilities:

DETOXIFICATION THERAPY - Designed to suit the needs of the client. The purpose is to begin to detoxify the body so that the following steps are more effective in boosting cellular nutrition (Mekenz h7 - Celltox). Available in oral or injectable form.

REVITALISATION THERAPY - may be general or organ-specific, through immunological embryonic organotherapy (Cellorgane Complex and Multi-complex.). Available in oral or injectable form.

TARGETED PRO-HORMONAL THERAPY FOR MEN AND WOMEN. (BIOFEMIN-ANDROCELL)

ANTI-AGEING CELLULAR REGENERATION THERAPY AVAILABLE IN ORAL OR INJECTABLE FORM. (HUMAN ULTRACELL 2G - HUMAN ULTRACELL 3G - HUMAN CITOPLACELL - REVERCELL)

IMMUNOCELLULAR-ANTI-INFLAMMATORY THERAPY. (BIOENZYM) Available in oral or injectable form.                 

EXTRACTING AND SECURING CELLULAR COMPOUNDS

Extraction begins in breeding farms in the south of France, in sheep and pigs, due to the compatibility of their organs to those of humans. The compounds are harvested from the animals during the embryonic stage, in the second month of gestation. The products are lyophilised, ultrafiltrated and certified as being free of prions, parasites, pyrogens, bacteria, nano-bacteria, fungi and viruses.

Many years of clinical experience have shown that pigs and sheep are the best donors, as they are strong and immunologically resistant. It's for this reason that most heart valves used in transplants in humans come from pigs. In addition, proteins from sheep and/or pigs are particularly compatible with the human body, especially in the embryonic stage, and very rarely trigger a host immune reaction.

These methods are continuously monitored by the French Agency for the Safety of Health Products (AFSSAPS), Management and Evaluation of Bio-medicines division, in order to ensure that they comply with the strictest biosecurity controls in place for therapeutic treatments. The diet and surroundings in which mother animals chosen as organ and embryo donors are raised are 100% organic, with periodic evaluations by bio-veterinarians.

PURPOSE

Biocell Ultravital has developed advanced pharmaceutical-grade biotechnology treatments known as CELLULAR RENOVATION THERAPY, comprised of different products and formulas that are successfully recommended around the world.

Therefore, our main purpose currently is to educate and work hand in hand with the medical community and with opinion leaders in the field of health services, in order to promote prevention as a new way of life, focusing on cellular nutrition through "Cellular Renovation Therapy."

The good news is that Biocell Ultravital's cellular treatments are now available in Mexico and are distributed exclusively to clinics and hospitals across the country through a program run by Mexico's Laboratorios Kurabiol, that includes conferences, workshops, and several training and certification courses.

It is not unlikely to predict that, by the year 2050, people 80 years old will be considered young adults, and those people who reach 100 years of age will undoubtedly be called upon to define a new era for seniors, in which they remain in good biological health.

The medicine of the future will be defined by three 'Ps':

Preventative: through Cellular Renovation Therapy

Predictive: by looking at each person's genetic profile

Personalised: through the participation of each individual in support of his or her health

A message for life: consult your doctor regularly. BIOCELL ULTRAVITAL Cellular Renovation Therapy.

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.

Policies

Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.

Privacy

This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2017 Biocell Ultravital